Royal Bank of Canada’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-35
Closed 7090
2024
Q4
$0 Buy
+35
New +$53 ﹤0.01% 7113
2024
Q3
Sell
-149
Closed -$1K 7220
2024
Q2
$1K Sell
149
-60
-29% -$544 ﹤0.01% 6858
2024
Q1
$3K Buy
209
+65
+45% +$772 ﹤0.01% 6603
2023
Q4
$2K Sell
144
-6
-4% -$68 ﹤0.01% 6821
2023
Q3
$1K Buy
150
+7
+5% +$86 ﹤0.01% 6912
2023
Q2
$3K Sell
143
-9
-6% -$210 ﹤0.01% 6794
2023
Q1
$3K Buy
152
+3
+2% +$76 ﹤0.01% 6699
2022
Q4
$4K Sell
149
-7
-4% -$233 ﹤0.01% 6796
2022
Q3
$5K Buy
156
+5
+3% +$196 ﹤0.01% 6737
2022
Q2
$6K Sell
151
-112
-43% -$4.27K ﹤0.01% 6585
2022
Q1
$11K Buy
263
+120
+84% +$4.42K ﹤0.01% 6907
2021
Q4
$7K Sell
143
-126
-47% -$6.74K ﹤0.01% 7147
2021
Q3
$17K Buy
269
+126
+88% +$5.44K ﹤0.01% 6771
2021
Q2
$6K Sell
143
-15,500
-99% -$666K ﹤0.01% 7028
2021
Q1
$821K Sell
15,643
-589
-4% -$39.5K ﹤0.01% 3760
2020
Q4
$1.1M Buy
16,232
+359
+2% +$16.6K ﹤0.01% 3404
2020
Q3
$608K Hold
15,873
﹤0.01% 3697
2020
Q2
$614K Buy
15,873
+52
+0.3% +$1.99K ﹤0.01% 3605
2020
Q1
$474K Buy
15,821
+118
+0.8% +$7.13K ﹤0.01% 3663
2019
Q4
$1.78M Buy
15,703
+60
+0.4% +$3.48K ﹤0.01% 2977
2019
Q3
$494K Sell
15,643
-38
-0.2% -$1.37K ﹤0.01% 3854
2019
Q2
$672K Hold
15,681
﹤0.01% 3637
2019
Q1
$855K Hold
15,681
﹤0.01% 3311
2018
Q4
$466K Hold
15,681
﹤0.01% 3754
2018
Q3
$722K Hold
15,681
﹤0.01% 3633
2018
Q2
$340K Sell
15,681
-2
-0% -$58 ﹤0.01% 4076
2018
Q1
$599K Buy
15,683
+8,995
+134% +$476K ﹤0.01% 3576
2017
Q4
$387K Sell
6,688
-83
-1% -$5.34K ﹤0.01% 3957
2017
Q3
$447K Sell
6,771
-2,405
-26% -$161K ﹤0.01% 3895
2017
Q2
$775K Buy
9,176
+2,495
+37% +$335K ﹤0.01% 3303
2017
Q1
$925K Buy
+6,681
New +$1.09M ﹤0.01% 3147

Other funds holding MTNB